Ultragenyx Pharmaceutical (RARE) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -22.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.52% |
| Dec 31, 2025 | -129.98% |
| Sep 30, 2025 | -35.12% |
| Jun 30, 2025 | 12.65% |
| Mar 31, 2025 | 11.53% |
| Dec 31, 2024 | 447.06% |
| Sep 30, 2024 | 16.37% |
| Jun 30, 2024 | 17.66% |
| Mar 31, 2024 | -4.09% |
| Dec 31, 2023 | 19.50% |
| Sep 30, 2023 | 34.87% |
| Jun 30, 2023 | -1.05% |
| Mar 31, 2023 | -7.65% |
| Dec 31, 2022 | -22.98% |
| Sep 30, 2022 | -235.77% |
| Jun 30, 2022 | -29.19% |
| Mar 31, 2022 | -11.88% |
| Dec 31, 2021 | -419.72% |
| Sep 30, 2021 | -6.03% |
| Jun 30, 2021 | -583.62% |
| Mar 31, 2021 | -14.38% |
| Dec 31, 2020 | 74.40% |
| Sep 30, 2020 | 39.07% |
| Jun 30, 2020 | 125.53% |
| Mar 31, 2020 | -23.02% |
| Dec 31, 2019 | -6.81% |
| Sep 30, 2019 | -29.42% |
| Jun 30, 2019 | -88.08% |
| Mar 31, 2019 | -419.82% |
| Dec 31, 2018 | 10.36% |
| Sep 30, 2018 | -10.20% |
| Jun 30, 2018 | 27.66% |
| Mar 31, 2018 | 144.30% |
| Dec 31, 2017 | -37.51% |
| Sep 30, 2017 | -22.06% |
| Jun 30, 2017 | -28.05% |
| Mar 31, 2017 | -29.74% |
| Dec 31, 2016 | -28.99% |
| Sep 30, 2016 | -65.31% |
| Jun 30, 2016 | -91.75% |
| Mar 31, 2016 | -147.95% |
| Dec 31, 2015 | -229.83% |
| Sep 30, 2015 | -150.66% |
| Jun 30, 2015 | -118.52% |
| Mar 31, 2015 | -55.75% |
| Dec 31, 2014 | -76.93% |
| Sep 30, 2014 | -103.61% |
| Jun 30, 2014 | -57.00% |
| Mar 31, 2014 | -101.60% |